Estimands—What they are and why they are important for pharmacometricians von Akacha, Mouna, Bartels, Christian, Bornkamp, Björn, Bretz, Frank, Coello, Neva, Dumortier, Thomas, Looby, Michael, Sander, Oliver, Schmidli, Heinz, Steimer, Jean‐Louis, Vong, Camille

Volltext

A framework to guide dose & regimen strategy for clinical drug development von Sander, Oliver, Magnusson, Baldur, Ludwig, Inga, Jullion, Astrid, Meille, Christophe, Lorand, Daniel, Bornkamp, Björn, Hinder, Markus, Kovacs, Steven J., Looby, Michael

Volltext

Characterization of the bronchodilatory dose response to indacaterol in patients with chronic obstructive pulmonary disease using model-based approaches von Renard, Didier, Looby, Michael, Kramer, Benjamin, Lawrence, David, Morris, David, Stanski, Donald R

Volltext

A novel model-based approach for dose determination of glycopyrronium bromide in COPD von Arievich, Helen, Overend, Tim, Renard, Didier, Gibbs, Michael, Alagappan, Vijay, Looby, Michael, Banerji, Donald

Volltext

Determination of the pharmacokinetics of glycopyrronium in the lung using a population pharmacokinetic modelling approach von Bartels, Christian, Looby, Michael, Sechaud, Romain, Kaiser, Guenther

Volltext

Pharmacokinetics of Lumiracoxib in plasma and synovial fluid von SCOTT, Graham, RORDORF, Christiane, REYNOLDS, Christine, KALBAG, Jyoti, LOOBY, Michael, MILOSAVLJEV, Slavica, WEAVER, Margaret, HUFF, John P, RUFF, Dennis A

Volltext

Benchmarking QSP Models Against Simple Models: A Path to Improved Comprehension and Predictive Performance von Stein, Andrew M., Looby, Michael

Volltext

Key Aspects of Modern, Quantitative Drug Development von Gibson, Eric, Bretz, Frank, Looby, Michael, Bornkamp, Bjoern

Volltext

Queer Natures, Queer Mythologies von Moffat, Wendy, Love, Heather, Herring, Scott, North, Michael, Looby, Christopher, See, Sam

Volltext

Population Pharmacokinetics of Fingolimod Phosphate in Healthy Participants von Wu, Kai, Mercier, Francois, David, Olivier J., Schmouder, Robert L., Looby, Michael

Volltext

Population pharmacokinetics and optimal design of paediatric studies for famciclovir von Ogungbenro, Kayode, Matthews, Ivan, Looby, Michael, Kaiser, Guenther, Graham, Gordon, Aarons, Leon

Volltext

Comment on the report "limitations of model-based dose selection for indacaterol in patients with chronic obstructive pulmonary disease" von Looby, Michael, Renard, Didier, Wright, Andrew, Morris, David, Stanski, Donald

Volltext

Population pharmacodynamic model of the longitudinal FEV1 response to an inhaled long-acting anti-muscarinic in COPD patients von Wu, Kai, Looby, Michael, Pillai, Goonaseelan, Pinault, Gregory, Drollman, Anton Franz, Pascoe, Steve

Volltext

Population pharmacodynamic model of the longitudinal FEV^sub 1^ response to an inhaled long-acting anti-muscarinic in COPD patients von Wu, Kai, Looby, Michael, Pillai, Goonaseelan, Pinault, Gregory, Drollman, Anton Franz, Pascoe, Steve

Volltext

What You Should Know About Harmonics von Looby, Michael

Volltext

DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST von DAVID, Olivier, DUMORTIER, Thomas, SCHMOUDER, Robert, LOOBY, Michael

Volltext bestellen

Dosage regimen for a S1P receptor agonist von David, Olivier, Dumortier, Thomas, Looby, Michael, Schmouder, Robert

Volltext bestellen

DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST von DAVID, Olivier, DUMORTIER, Thomas, SCHMOUDER, Robert, LOOBY, Michael

Volltext bestellen

DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST von David, Olivier, Dumortier, Thomas, Looby, Michael, Schmouder, Robert

Volltext bestellen

DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST von DAVID, Olivier, DUMORTIER, Thomas, SCHMOUDER, Robert, LOOBY, Michael

Volltext bestellen